Substance use treatment; Detoxification; Outpatient; Outpatient detoxification; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment; Buprenorphine used in Treatment; Naltrexone used in Treatment; In-network prescribing entity; Does not use medication assisted treatment for alcohol use disorder; Buprenorphine maintenance; Prescribes buprenorphine; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (extended-release, injectable); Clonidine; Cognitive behavioral therapy; Contingency management/motivational incentives; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; 12-step facilitation; Private non-profit organization; State Substance use treatment agency; The Joint Commission; Federal, or any government funding for substance use treatment programs; Adult men; Clients with co-occurring mental and substance use disorders; Comprehensive substance use assessment; Interim services for clients; Outreach to persons in the community; Screening for tobacco use; Screening for substance use; Screening for mental disorders; Drug or alcohol urine screening; TB screening; Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Self-help groups; Mentoring/peer support; Substance use disorder education; Individual counseling; Group counseling; Smoking permitted in designated area; Adults; Young adults; Male; Vaping not permitted; Transportation assistance